SOX2 and plasma cell myeloma: Therefore, in this study, we only demonstrated that ALKBH5 increased the percentage of SP cells and CD138-/CD34- myeloma stem cells by activating cancer stem cell related HIPPO pathway signalling and promoting the expression of pluripotency factors NANOG, SOX2 and OCT4.